Cresset Establishes new Versaphor Division to Provide High-quality Desktop Products
Product News Mar 03, 2010
Cresset has announced that it has launched Versaphor, a new desktop applications division aimed at supplying high quality tools based on its molecular Fields technology to a range of markets, including: medicinal chemists, patent teams (internal and external counsel), pre-clinical safety teams and in-licensing teams.
Versaphor’s Field-based tools enable companies to find smarter answers to their chemistry questions and make better-informed decisions about which molecules deserve investment of time, effort and capital. Versaphor’s first products are medicinal chemistry and patent specific versions of the FieldStere bioisostere generator.
The Medicinal Chemistry application allows medicinal chemists to generate highly ideas for drug-like lead molecules in new areas of chemical space. The Patent application enables patent attorneys to identify and evaluate the ‘obviousness’ of new chemical filings and to develop stronger patent filings covering a wider range of structural diversity.
Cresset’s Field-based tools have been used by Computational Chemists for over 8 years to predict and compare the activity and properties of their lead compounds. Instead of relying on 2D structure, Cresset uses the Fields around molecules to assess their likely biological activity and properties, regardless of structural similarity. Cresset’s Fields provide a highly-condensed representation of the nature, size and location of the critical properties required for binding and instigating a specific therapeutic effect.